OBD vs. FUM, SBTX, TRX, COS, C4XD, DDDD, OKYO, SAR, AREC, and AOR
Should you be buying Oxford BioDynamics stock or one of its competitors? The main competitors of Oxford BioDynamics include Futura Medical (FUM), SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), Sareum (SAR), Arecor Therapeutics (AREC), and AorTech International (AOR). These companies are all part of the "biotechnology" industry.
Oxford BioDynamics vs. Its Competitors
Oxford BioDynamics (LON:OBD) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.
Oxford BioDynamics has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.
In the previous week, Futura Medical had 1 more articles in the media than Oxford BioDynamics. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Oxford BioDynamics. Futura Medical's average media sentiment score of 1.11 beat Oxford BioDynamics' score of 0.00 indicating that Futura Medical is being referred to more favorably in the news media.
44.3% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 35.7% of Futura Medical shares are owned by institutional investors. 16.8% of Oxford BioDynamics shares are owned by company insiders. Comparatively, 32.1% of Futura Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Futura Medical has a net margin of -44.64% compared to Oxford BioDynamics' net margin of -1,800.32%. Futura Medical's return on equity of -56.44% beat Oxford BioDynamics' return on equity.
Futura Medical has higher revenue and earnings than Oxford BioDynamics. Futura Medical is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.
Summary
Futura Medical beats Oxford BioDynamics on 11 of the 13 factors compared between the two stocks.
Get Oxford BioDynamics News Delivered to You Automatically
Sign up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OBD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford BioDynamics Competitors List
Related Companies and Tools
This page (LON:OBD) was last updated on 8/2/2025 by MarketBeat.com Staff
Free OBD Stock Alerts